A desi dengue vaccine is undergoing the third phase of clinical trials, a top ICMR official has said. The trial, to develop a vaccine to contain dengue, which takes thousands of lives every year during the rainy season, involves over 10,000 adult participants from more than 15 states. The vaccine DengiAll is expected to hit the markets by mid-next year.